上海华依科技集团股份有限公司2025 年第一季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整，不存 在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中财务信息 的真实、准确、完整。 第一季度财务报表是否经审计 □是 √否 一、主要财务数据 (一)主要会计数据和财务指标 1 / 11 证券代码：688071 证券简称：华依科技 上海华依科技集团股份有限公司 2025 年第一季度报告 项目 本报告期 上年同期 本报告期比上 年同期增减变 动幅度(%) 营业收入 141,539,417.80 101,813,147.41 39.02 归属于上市公司股东的净利润 2,957,040.69 -9,692,729.53 不适用 归属于上市公司股东的扣除非经常 性损益的净利润 1,345,649.70 -10,776,399.21 不适用 经营活动 ...

上海华依科技集团股份有限公司2024 年年度报告 公司代码：688071 公司简称：华依科技 上海华依科技集团股份有限公司 2024 年年度报告 1 / 242 上海华依科技集团股份有限公司2024 年年度报告 重要提示 一、本公司董事会、监事会及董事、监事、高级管理人员保证年度报告内容的真实性、准确性、 完整性，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 二、公司上市时未盈利且尚未实现盈利 □是 √否 三、重大风险提示 公司已在本报告中详细阐述公司在生产经营过程中面临的各种风险及应对措施，敬请查阅"第 三节 管理层讨论与分析"之"四、风险因素"。敬请投资者注意投资风险。 四、 上会会计师事务所（特殊普通合伙）为本公司出具了标准无保留意见的审计报告。 五、公司全体董事出席董事会会议。 六、公司负责人励寅、主管会计工作负责人潘旻及会计机构负责人（会计主管人员）蒋程声明： 保证年度报告中财务报告的真实、准确、完整。 √适用 □不适用 本报告所涉及的未来计划、发展战略等前瞻性陈述，不构成公司对投资者的实质承诺，请投 资者注意投资风险。 十、是否存在被控股股东及其他关联方非经营性占用资金情况 ...

Financial Performance - The company's revenue for Q1 2025 reached ¥520,727,956.78, representing a year-on-year increase of 6.51% compared to ¥488,922,961.14 in the same period last year[4] - Net profit attributable to shareholders was ¥58,280,864.69, up 20.46% from ¥48,382,271.21 in the previous year[4] - The net profit after deducting non-recurring gains and losses was ¥50,417,709.02, reflecting a 27.33% increase from ¥39,595,241.44 year-on-year[4] - Total operating costs for Q1 2025 were ¥446,711,595.40, slightly up from ¥443,023,742.31 in Q1 2024[19] - Net profit for Q1 2025 was ¥93,391,185.99, representing a 10.4% increase from ¥84,377,327.74 in Q1 2024[19] - Earnings per share for Q1 2025 were ¥0.47, compared to ¥0.45 in Q1 2024[20] Cash Flow - The company's cash flow from operating activities showed a significant decline, with a net outflow of ¥63,902,376.24, down 121.46% from a net inflow of ¥297,713,925.67 in the same period last year[4] - Cash flow from operating activities in Q1 2025 was ¥434,703,349.93, down from ¥676,149,965.93 in Q1 2024[21] - The net cash inflow from operating activities was -$63.90 million, a significant decrease compared to $297.71 million in the previous period[22] - The total cash outflow from operating activities was $536.70 million, compared to $436.64 million in the prior period[22] Assets and Liabilities - Total assets increased by 5.59% to ¥5,481,796,232.37 from ¥5,191,806,039.68 at the end of the previous year[5] - Total liabilities rose to ¥3,018,232,333.17, compared to ¥2,824,071,977.49 in the previous year[17] - The company's total current assets increased to ¥3,719,615,799.66 as of March 31, 2025, up from ¥3,449,718,778.78 on December 31, 2024, reflecting a growth of approximately 7.8%[15] - Accounts receivable decreased to ¥605,253,130.39 from ¥689,230,875.28, a decline of about 12.2%[15] - Inventory increased significantly to ¥1,138,569,566.79 from ¥974,317,970.48, marking an increase of approximately 16.9%[15] - Long-term receivables increased to ¥11,320,136.02 from ¥5,465,030.24, showing a growth of approximately 107.5%[15] Shareholder Information - Total number of common shareholders at the end of the reporting period is 9,754[11] - The largest shareholder, Wang Yinglin, holds 27,123,764 shares, representing 21.69% of total shares[11] - The company declared a cash dividend of ¥0.30 per share and a capital reserve conversion of 4 shares for every 10 shares held, based on a total share capital of 89,321,603 shares[5] Research and Development - Research and development expenses totaled ¥30,283,431.26, which is 12.77% higher than the ¥26,855,110.37 spent in the previous year, accounting for 5.82% of total revenue[5] - The company reported a significant increase in R&D expenses, totaling ¥30,283,431.26 in Q1 2025, up from ¥26,855,110.37 in Q1 2024[19] Non-Recurring Items - Non-recurring gains and losses for the period amounted to ¥7,863,155.67, after accounting for tax effects and minority interests[9]

广州达安基因股份有限公司 2025 年第一季度报告 广州达安基因股份有限公司 2025 年第一季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重 大遗漏。 证券代码：002030 证券简称：达安基因 公告编号：2025-021 重要内容提示： 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记 载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季度报告中财务 信息的真实、准确、完整。 3.第一季度报告是否经审计 □是 否 1 广州达安基因股份有限公司 2025 年第一季度报告 一、主要财务数据 □是 否 | | 本报告期 | 上年同期 | 本报告期比上年同期增减 | | --- | --- | --- | --- | | | | | （%） | | 营业收入（元） | 169,136,638.98 | 198,307,676.45 | -14.71% | | 归属于上市公司股东的净利 | 52,924,282.00 | -363,290,638. ...

杭州滨江房产集团股份有限公司 2025 年第一季度报告 证券代码：002244 证券简称：滨江集团 公告编号：2025-024 杭州滨江房产集团股份有限公司 2025 年第一季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 （一） 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 否 | | 本报告期 | 上年同期 | 本报告期比上年同期增减 | | --- | --- | --- | --- | | | | | （%） | | 营业收入（元） | 22,507,750,130.36 | 13,701,341,078.30 | 64.27% | | 归属于上市公司股东的净利润（元） | 975,913,324.17 | 659,941,352.50 | 47.88% | | 归属于上市公司股东的扣除非经常性 损益的净利润（元） | 959,546,408.88 | 648,294,886.68 | 48.01% | | 经营活动产生的现金流量净额（元） | -6,120,208,570.81 | -2,377,461,362.61 ...

2025 年第一季度报告 证券代码：002078 证券简称：太阳纸业 公告编号：2025-014 山东太阳纸业股份有限公司 2025 年第一季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或重大遗漏。 重要内容提示： 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、误导性陈述或重 大遗漏，并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季度报告中财务信息的真实、准确、 完整。 3.第一季度报告是否经审计 □是 否 1 2025 年第一季度报告 一、主要财务数据 （一） 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 否 | | 本报告期 | 上年同期 | 本报告期比上年同期增减 | | --- | --- | --- | --- | | | | | （%） | | 营业收入（元） | 9,897,728,415.84 | 10,184,934,449.35 | -2.82% | | 归属于上市公司股东的净利 | 886,069,341.18 ...

Financial Performance - The company's operating revenue for Q1 2025 was ¥319,553,524.37, a decrease of 22.89% compared to ¥414,424,207.46 in the same period last year[5] - The net loss attributable to shareholders for Q1 2025 was ¥17,596,540.58, representing an increase in loss of 81.55% from a loss of ¥9,692,588.71 in the previous year[5] - Basic and diluted earnings per share for Q1 2025 were both -¥0.0992, reflecting an 81.68% increase in loss per share from -¥0.0546 in the same quarter last year[5] - Net profit for the period was a loss of ¥16,367,411.77, compared to a loss of ¥9,382,097.55 in the previous period, indicating a worsening of approximately 74%[20] - The total comprehensive income for the period was a loss of ¥16,367,411.77, compared to a loss of ¥9,382,097.55 in the previous period, indicating a decline of approximately 74%[20] Cash Flow - The net cash flow from operating activities was -¥66,484,808.34, a significant decline of 898.63% compared to a positive cash flow of ¥8,324,893.85 in Q1 2024[5] - Operating cash flow generated a net outflow of ¥66,484,808.34, contrasting with a net inflow of ¥8,324,893.85 in the previous period[21] - The net cash flow from investing activities was ¥38,252,170.79, a significant increase of 4,400.59% from -¥889,464.09 in Q1 2024, mainly due to the maturity of financial products[9] - Investment activities generated a net cash inflow of ¥38,252,170.79, compared to a net outflow of ¥889,464.09 in the previous period[22] Assets and Liabilities - Total assets at the end of Q1 2025 were ¥1,207,263,086.93, a decrease of 1.42% from ¥1,224,640,744.27 at the end of the previous year[5] - The company's cash and cash equivalents decreased to CNY 223,812,994.55 from CNY 252,976,802.02, reflecting a decline of approximately 11.5%[16] - Accounts receivable increased to CNY 196,521,068.98 from CNY 170,450,036.30, representing a growth of about 15.3%[16] - The total liabilities of the company decreased slightly to CNY 289,091,586.16 from CNY 290,101,831.73, indicating a reduction of approximately 0.3%[18] - The company's equity attributable to shareholders decreased to CNY 915,126,527.48 from CNY 932,723,068.06, a decline of about 1.9%[18] - The company reported a total current asset of CNY 870,739,050.69, down from CNY 887,558,100.23, a decrease of approximately 1.9%[16] - The company’s non-current assets totaled CNY 336,524,036.24, slightly down from CNY 337,082,644.04, reflecting a decrease of about 0.2%[17] - The company’s total equity increased to CNY 918,171,500.77 from CNY 934,538,912.54, a decrease of approximately 1.8%[18] Expenses - Research and development expenses decreased by 35.49% to ¥3,953,823.49 from ¥6,129,141.14 in Q1 2024, attributed to optimization of the R&D team structure[9] - Total operating costs decreased to ¥333,113,206.60 from ¥422,341,670.49, a reduction of about 21% year-over-year[19] - The company reported a significant increase in credit impairment losses, amounting to -¥1,374,334.11, compared to -¥2,113,097.12 in the previous period[20] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 34,279, with the largest shareholder holding 32.76% of the shares[11] - The company received government subsidies amounting to ¥158,531.17 during the reporting period, contributing to other income[6] - The company will suspend trading of its shares starting October 30, 2024, due to uncertainties related to the acquisition transaction[13] - The company plans to acquire 100% equity of Shanghai Jiatu Internet Technology Group Co., Ltd. through a combination of issuing shares and cash payment, which will make Jiatu Group a wholly-owned subsidiary of the company[13]

湖北能特科技股份有限公司 2025 年第一季度报告 证券代码：002102 证券简称：能特科技 公告编号：2025-054 湖北能特科技股份有限公司 2025 年第一季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 重要内容提示： 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、 误导性陈述或重大遗漏，并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季度报告中财务信息 的真实、准确、完整。 3.第一季度报告是否经审计 □是 否 公司是否需追溯调整或重述以前年度会计数据 □是 否 | | 本报告期 | 上年同期 | 本报告期比上年同期增 | | --- | --- | --- | --- | | | | | 减（%） | | 营业收入（元） | 2,877,267,078.75 | 3,040,918,454.16 | -5.38% | | 归属于上市公司股东的 | 215,904,213.86 | 55,760,878.81 | 287.20% | | ...

河南蓝天燃气股份有限公司2025 年第一季度报告 证券代码：605368 证券简称：蓝天燃气 河南蓝天燃气股份有限公司 2025 年第一季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整，不存 在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中财务信息 的真实、准确、完整。 第一季度财务报表是否经审计 □是 √否 一、主要财务数据 (一)主要会计数据和财务指标 单位：元 币种：人民币 | | | | 本报告期比上年同 | | --- | --- | --- | --- | | 项目 | 本报告期 | 上年同期 | 期增减变动幅度 | | | | | (%) | | 营业收入 | 1,396,134,744.29 | 1,581,736,259.77 | -11.73 | | 归属于上市公司股东的净利 润 | 132,017,273.89 | ...

Financial Performance - The company's operating revenue for Q1 2025 was CNY 229,843,941.53, representing a 3.60% increase compared to CNY 221,850,180.79 in the same period last year[4]. - Net profit attributable to shareholders was CNY 58,071,117.89, up 5.20% from CNY 55,199,616.28 year-on-year[4]. - The net profit excluding non-recurring gains and losses was CNY 52,698,123.38, reflecting a 7.81% increase from CNY 48,882,462.10 in the previous year[4]. - Basic and diluted earnings per share were both CNY 0.15, an increase of 7.14% from CNY 0.14 in the same quarter last year[4]. - Total operating revenue for Q1 2025 reached CNY 229,843,941.53, an increase of 3.4% compared to CNY 221,850,180.79 in Q1 2024[18]. - Net profit for Q1 2025 was CNY 58,030,577.70, representing a 3.5% increase from CNY 55,107,063.21 in Q1 2024[19]. - Earnings per share for Q1 2025 were CNY 0.15, up from CNY 0.14 in Q1 2024[20]. Research and Development - Total R&D investment amounted to CNY 26,897,460.32, a decrease of 23.13% from CNY 34,991,868.71 in the previous year, with R&D expenses accounting for 11.70% of operating revenue, down from 15.77%[4]. - Research and development expenses for Q1 2025 totaled CNY 26,897,460.32, down from CNY 34,991,868.71 in Q1 2024[18]. Assets and Liabilities - The company's total assets at the end of the reporting period were CNY 3,473,532,404.39, a slight increase of 0.22% from CNY 3,465,734,982.98 at the end of the previous year[5]. - The total current liabilities decreased from RMB 227,845,174.60 to RMB 198,903,468.21, a reduction of approximately 12.7%[16]. - The company's total liabilities decreased to CNY 594,157,689.89 from CNY 644,390,846.18 year-over-year[18]. - The total equity attributable to shareholders increased to CNY 2,877,973,401.17 from CNY 2,819,902,283.28[18]. Cash Flow - The net cash flow from operating activities improved significantly, with a net outflow of CNY -75,343,585.60 compared to CNY -129,613,339.07 in the same period last year[4][9]. - Cash flow from operating activities in Q1 2025 was CNY 154,928,044.70, a decrease from CNY 211,271,503.82 in Q1 2024[21]. - Operating cash inflow totaled $160,007,655.13, a decrease from $217,425,731.31 year-over-year[22]. - Operating cash outflow amounted to $235,351,240.73, down from $347,039,070.38 year-over-year[22]. - Net cash flow from operating activities was -$75,343,585.60, compared to -$129,613,339.07 in the previous year[22]. - Cash and cash equivalents at the end of the period were $1,796,034,364.28, compared to $1,220,123,829.78 at the end of the previous year[23]. - The net increase in cash and cash equivalents was $657,016,713.62, contrasting with a decrease of $45,889,245.89 in the prior year[23]. Shareholder Information - The company reported a total of 7,182 ordinary shareholders, with 7,167 holding A shares and 15 holding H shares[14]. - The top ten shareholders include Beijing Panmao Investment Management Co., Ltd. with 17,250,000 shares, representing a significant stake in the company[14]. - The company has not reported any changes in the participation of major shareholders in margin financing and securities lending activities[15]. Other Information - The company received government subsidies amounting to CNY 1,038,221.69, which are closely related to its normal business operations[6]. - Non-recurring gains and losses totaled CNY 5,372,994.51 after tax and minority interest adjustments[7]. - The company has not disclosed any significant new strategies or product developments during the reporting period[15]. - The company plans to implement new accounting standards starting in 2025, which may affect financial reporting[23].